Intarcia Therapeutics Inc - Company Review
Intarcia Therapeutics Inc - Company ReviewSummary
Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc, is a biopharmaceutical company that discovers, develops and commercializes drug therapies and reduces effects for chronic diseases. The company’s product candidate include ITCA 650 is in Phase III clinical trial. Its ITCA 650 is used for the treatment of type II diabetes and obesity. Intarcia offers technology platform delivery feasibility testing that helps to develop proprietary formulations and evaluation of drug candidates the formulations. The company uses medical drug delivery system, a proprietary technology platform to develop the drugs. It operates through its manufacturing facility in Hayward, California. Intarcia is headquartered in Boston, Massachusetts, the US.
This comprehensive company report of Intarcia Therapeutics Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.